Table 2.
Abbott anti-S |
Abbott anti-N |
P valuee | |||||
---|---|---|---|---|---|---|---|
Non-severe patients | Negative | Positive | % positive [CI] | Negative | Positive | % positive [CI] | |
0−59 d | 8 | 102 | 92.7% [86.1−96.5] | 18 | 92 | 83.6% [75.5−89.5] | P = 0.06 |
60−119 d | 2 | 68 | 97.1% [89.6−99.8] | 11 | 59 | 84.3% [73.8−91.2] | P < 0.05 |
120−179 d | 0 | 58 | 100% [92.6−100] | 18 | 40 | 69.0%c [56.1−79.4] | P < 0.01 |
180−239 d | 3 | 47 | 94.0% [83.2−98.6] | 27 | 23 | 46.0%d [33.0−59.6] | P < 0.01 |
240−299 d | 2 | 39 | 95.1% [83.0−99.5] | 23 | 18 | 43.9%d [29.9−59.0] | P < 0.01 |
300−365 d | 6 | 27 | 81.8% [65.2−91.8] | 23 | 10 | 30.3%d [17.3−47.5] | P < 0.01 |
Severe Patients | Negative | Positive | % positive [CI] | Negative | Positive | % positive [CI] | |
0−59 d | 5 | 108 | 95.6% [89.8−98.4] | 1 | 112 | 99.1%b [94.6−100] | P = 0.21 |
60−119 d | 1 | 81 | 98.8% [92.8−100] | 1 | 81 | 98.8%b [92.8−100] | P = 1.0 |
120−179 d | 1 | 51 | 98.1% [88.9-100] | 4 | 48 | 92.3%b,c [81.3−97.5] | P = 0.36 |
180−239 d | 2 | 31 | 93.9% [79.4−99.3] | 9 | 24 | 72.7%a,d [55.6−85.1] | P < 0.05 |
240−299 d | 1 | 33 | 97.1% [83.8−100] | 12 | 22 | 64.6%d [48.9−78.6] | P < 0.01 |
300−365 d | 1 | 22 | 95.7% [77.3−100] | 10 | 13 | 56.5%d [36.8−74.4] | P < 0.01 |
CI = 95% confidence interval.
P < 0.05 vs non-severe,
P < 0.01 vs non-severe,
P < 0.05 vs day 0 to 59,
P < 0.01 vs day 0 to 59,
Anti-S vs anti-N.